...
首页> 外文期刊>Journal of Clinical Microbiology >Multicenter Clinical Evaluation of the Revogene Strep A Molecular Assay for Detection of Streptococcus pyogenes from Throat Swab Specimens
【24h】

Multicenter Clinical Evaluation of the Revogene Strep A Molecular Assay for Detection of Streptococcus pyogenes from Throat Swab Specimens

机译:复发术临床评价的临床评价用于检测<命名含量含量型=“属型”>链球菌的咽部棉签(喉部)的分子测定

获取原文
           

摘要

Group A streptococcus (GAS) species cause bacterial pharyngitis in both adults and children. Early and accurate diagnosis of GAS is important for appropriate antibiotic therapy to prevent GAS sequalae. The Revogene Strep A molecular assay (Meridian Bioscience Canada Inc, Quebec City, QC, Canada) is an automated real-time PCR assay for GAS detection from throat swab specimens within approximately 70 min. This multicenter prospective study evaluated the performance of the Revogene Strep A molecular assay compared to that of bacterial culture. ABSTRACT Group A streptococcus (GAS) species cause bacterial pharyngitis in both adults and children. Early and accurate diagnosis of GAS is important for appropriate antibiotic therapy to prevent GAS sequalae. The Revogene Strep A molecular assay (Meridian Bioscience Canada Inc, Quebec City, QC, Canada) is an automated real-time PCR assay for GAS detection from throat swab specimens within approximately 70 min. This multicenter prospective study evaluated the performance of the Revogene Strep A molecular assay compared to that of bacterial culture. Dual throat swab specimens in either liquid Amies or Stuart medium were collected from eligible subjects (pediatric population and adults) enrolled across 7 sites (USA and Canada). Revogene Strep A and reference testing was performed within 7?days and 48 h of sample collection, respectively. Of the 604 evaluable specimens, GAS was detected in 154 (25.5%) samples by the reference method and in 175 (29%) samples by the Revogene Strep A assay. Revogene Strep A assay sensitivity and specificity were reported to be 98.1% (95% confidence interval [CI], 94.4 to 99.3) and 94.7% (95% CI, 92.2 to 96.4), respectively. The positive predictive value was 86.3% (95% CI, 80.4 to 90.6), negative predictive value was 99.3% (95% CI, 98.0 to 99.8) with a 1.0% invalid rate. Discrepant analysis with alternative PCR/bidirectional sequencing was performed for 24 false-positive (FP) and 3 false-negative (FN) specimens. Concordant results were reported for 17 (FP only) of 27 discordant specimens. The Revogene Strep A assay had high sensitivity and specificity for GAS detection and provides a faster alternative for GAS diagnosis.
机译:组链球菌(气体)物种在成人和儿童中引起细菌咽炎。早期准确的气体诊断对于适当的抗生素治疗是重要的,以防止汽葡萄酒酸队。 Revogene Strep A分子测定(Meridian Bioscience Canada Inc,魁北克市,QC,加拿大)是一种自动实时PCR测定,用于喉咙拭子试样在大约70分钟内的气体检测。该多中心前瞻性研究评估了与细菌培养相比,对分子测定的分子测定的性能进行了评价。摘要组链球菌(气体)物种在成人和儿童中引起细菌咽炎。早期准确的气体诊断对于适当的抗生素治疗是重要的,以防止汽葡萄酒酸队。 Revogene Strep A分子测定(Meridian Bioscience Canada Inc,魁北克市,QC,加拿大)是一种自动实时PCR测定,用于喉咙拭子试样在大约70分钟内的气体检测。该多中心前瞻性研究评估了与细菌培养相比,对分子测定的分子测定的性能进行了评价。从符合条件的受试者(儿科人口和成人)收集液体琥珀色或斯图尔特培养基中的双喉拭子标本从7位点(美国和加拿大)收集。 Revogene Strep A和参考测试分别在7.天和48小时内进行的样品收集。在604个可评估的标本中,通过参考方法和175(29%)样品在154(25.5%)样品中检测到气体,通过Revogene Strep A测定。 Revogene Strep分别报告了测定敏感性和特异性,分别为98.1%(95%置信区间[CI],94.4至99.3)和94.7%(95%CI,92.2至96.4)。阳性预测值为86.3%(95%CI,80.4至90.6),负预测值为99.3%(95%CI,98.0至99.8),率无效1.0%。使用替代PCR /双向测序的差异分析对24个假阳性(FP)和3个假阴性(FN)样本进行。报告了27个不和谐的标本的17个(FP)的一致结果。 Revogene Strep A测定对气体检测具有高灵敏度和特异性,并提供了较快的气体诊断替代品。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号